Pharmaceutical market in the Asia-Pacific region has been continuously gaining a larger share of the global pharma industry. This is due to the fact that, more and more pharma companies have been shifting their research and manufacturing operations to this region. Important pharmaceutical markets like, China, South Korea, India, Vietnam, and Indonesia will continue to grow at a healthy growth rate despite challenges in regulatory conditions. The region will continue to witness this growing trend, hence, the Asia-Pacific market is anticipated to grow at a CAGR of nearly 12% during 2011 - 2013, says our new research report “Asia Pacific Pharma Sector Analysis”.
Our team of experts has found that, another important driver for growth, apart from the government’s support has been the entry of global pharma giants in the region. Asia-Pacific is currently witnessing influx of multinational companies, and the region’s own pharma companies are expanding by acquiring international market share. We have found that as the entities in Asia offer infrastructure support and incentives, competition among countries to attract international pharmaceutical companies is increasing.
Our report has identified countries, which have emerged as fast growing pharmaceutical markets and have propelled the growth of pharmaceutical market in the Asia Pacific region. Countries covered in the report are Japan, China, India, South Korea, the Philippines, Vietnam, Indonesia, Malaysia, Thailand, Australia, and New Zealand. Besides, detail information regarding generics, patented drugs, OTC drug market, and prescription drugs have been included for all the countries.
“Asia Pacific Pharma Sector Analysis” also provides information of the key competitors in each country along with their business information and areas of expertise. It provides segment level analysis of the industry along with emerging trends that may shape up with the betterment of economic conditions. The research will help consultants, industry analysts, and vendors to get in-depth knowledge of the current, past, and future performance of the industry. The report provides an extensive research on the recent trends of the Asia Pacific Pharma market along with impartial analysis considering the impact of financial crisis on its performance.
For more information visit: http://www.rncos.com/Report/IM226.htm |
